FREE Case Review (866) 588-0600

Olumiant Lawsuit | Get the Right Lawyer

The U.S. Food and Drug Administration (FDA) is warning that side effects of the rheumatoid arthritis drug Olumiant (generic: baricitinib) may include an increased risk for serious heart-related events, cancer, blood clots and death.
Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt
Free Consultation
If you or a loved one was harmed by the side effects of Olumiant, you should contact our pharmaceutical law firm immediately.

You may be entitled to file a lawsuit and we can help. Please click the button below for a Free Confidential Case Evaluation or call us toll-free 24 hrs/day for legal advice by dialing (866) 588-0600.

Start My Free Case Evaluation

What is Olumiant?

Olumiant (baricitinib) is a prescription medicine used to treat adults with moderately to severely active rheumatoid arthritis (RA) who have tried at least 1 other medicine called a tumor necrosis factor (TNF) antagonist that did not work well enough or could not be tolerated. The drug was approved by the FDA on May 31, 2018.

Olumiant Labeling to Carry Warning for Heart Attack, Cancer, Blood Clots, Death

The FDA on September 1, 2021, announced that it was requiring revisions to the Boxed Warning (1) on Olumiant and 2 other similar Janus Kinase (JAK) inhibitor drugs, Xeljanz/Xeljanz XR (tofacitinib) and Rinvoq (upadacitinib), to include information about the risks of serious heart-related events, cancer, blood clots, and death.

“Based on the review of a large randomized safety clinical trial, the FDA has concluded there is an increased risk of serious heart-related events such as heart attack or stroke, cancer, blood clots, and death with the arthritis and ulcerative colitis medicines Xeljanz and Xeljanz XR,” FDA said. “The FDA is requiring new and updated warnings for two other arthritis medicines in the same drug class as Xeljanz, called Janus kinase (JAK) inhibitors, Olumiant and Rinvoq.”

Olumiant Side Effects

Serious side effects of Olumiant may include:

  • Heart-related events
  • Heart attack
  • Stroke
  • Cancer
  • Blood clots
  • Lymphoma
  • Lung cancer
  • Death

More moderate side effects of Olumiant may include:

  • Upper respiratory tract infections (such as a cold or sinus infection)
  • Nausea
  • Cold sores
  • Shingles

FDA Recommendation

If you are taking Olumiant, you should tell your health care professional if you are a current or past smoker, or have had a heart attack, other heart problems, stroke, or blood clots in the past as these may put you at higher risk for serious problems with the drug. You should seek emergency help right away if you have any symptoms that may signal a heart attack, stroke, or blood clot.

See all related cases on dangerous drugs lawsuits that we’ve taken on.

Get a Free Olumiant Lawsuit Evaluation With Our Lawyers

The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Olumiant lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Case Evaluation: Again, if you were harmed by Olumiant side effects, you should contact Schmidt and Clark’s lawyers immediately. You may be entitled to a settlement by filing an Olumiant lawsuit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.